Topics

Companies Related to "Pieris Pharmaceuticals Presents Data Demonstrating Monotherapy Clinical Benefit" [Most Relevant Company Matches] RSS

18:10 EST 15th December 2019 | BioPortfolio

Here are the most relevant search results for "Pieris Pharmaceuticals Presents Data Demonstrating Monotherapy Clinical Benefit" found in our extensive corporate database of over 50,000 company records.

Showing "Pieris Pharmaceuticals Presents Data Demonstrating Monotherapy Clinical Benefit" Companies 1–25 of 9,500+

Relevant

Pieris AG

Pieris was established in January 2001 with the vision of commercially exploiting technologies developed originally by Prof. Dr. Arne Skerra, Head of the Department of Biological Chemistry at the Technical University of Munich (TUM), Germany. While the scientific excellence of Prof. Dr. Skerra and his fellow Pieris co-founders has long been recognized by the academic community, the product commerc...


Emerge Clinical Solutions

Emerge offers unparalleled clinical data support and documentation to medical professionals. Through sophisticated analysis of electronic medical records, Emerge identifies potential inconsistencies within EHR data and presents doctors with patient-specific care-paths per the latest guidelines. Increased efficiency and enhanced risk detection are delivered...

Inotek Pharmaceuticals Corp.

Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other eye diseases. The Company’s lead product candidate, trabodenoson, is a first-in-class selective adenosine mimetic developed in Inotek’s laboratories designed to restore the eye’s ...


ObvioHealth

ObvioHealth is a full-service CRO that uses technology to drive clinical research in a cost-effective manner. As a medical technology company, ObvioHealth provides healthcare clients a data-rich platform for substantiating claims and demonstrating product safety and efficacy.

Caremark Rx Incorporated

Caremark Rx, Inc. (formerly MedPartners Inc.),a Delaware Corporation, is one of the largest pharmaceutical services companies in the United States, with net revenue of approximately $4.3 billion for 2000. The Company's operations are conducted through Caremark Inc., which provides pharmacy benefit management services and therapeutic pharmaceutical services. These services are sold separately and t...

Benefit Express

At Benefit Express, our focus is on flexible administration solutions. Our self-service platform - My Benefit Express (TM) - delivers tools which help you efficiently manage HR & Benefits Administration. With My Benefit Express (TM) clients have direct access to: customized content delivery, enrollment assistance, employee benefit education tools, transactional administrative processing/tracking, ...

NovoLogix

NovoLogix, Inc. is a medical pharmacy benefit management company delivering a breakthrough Software-as-a-service (SaaS) medical pharmacy information system called MedRx. NovoLogix manages the pharmaceuticals covered under an insurer’s medical benefit. Drugs covered under the medical benefit are usually dispensed in either a physician’s office or ...

Robin Dennison Presents, Inc

Robin Donohoe Dennison has 30 years of experience in critical care nursing, working as a staff nurse, nurse educator, clinical nurse specialist, consultant, and professor. Dr. Dennison’s educational background includes AA in nursing from Morris Harvey College (now University of Charleston) in Charleston, WV, BSN from Marshall University in Huntington, West Virginia, MSN in Cardiopulmonary Nursin...

Geneva Healthcare

Geneva Healthcare is focused on building the leading cardiac device data management suite. The Geneva Healthcare Suite transforms cardiac device data into actionable information for providers, physicians, payers and patients, improving the quality of care while increasing efficiency and lowering costs. The suite’s unique dashboard presents patient data in a ...

Sristek

Data is critical. And it should be managed right, especially, for clinical trials, which is a tedious and time consuming process. Even the most minute aspects demand proven expertise and innovation in order to generate the most accurate results and analysis. In such a scenario, why not get the expert brains to manage it for you. Get Sristek into your business.Sristek is the mindware for complete d...

NOXXON Pharma N.V.

NOXXON’s oncology-focused pipeline acts on the tumor microenvironment (TME) and the cancer immunity cycle by breaking the tumor protection barrier and blocking tumor repair. By neutralizing chemokines in the tumor microenvironment, NOXXON’s approach works in combination with other forms of treatment to weaken tumor defenses against the immune system and enable greater therapeutic impact...

The Center for Clinical Research Practice

This award-winning journal, edited with high editorial standards, provides you with informative articles and useful clinical research management tools. With six issues per year, Research Practitioner presents the most pertinent and useful information on the conduct and oversight of clinical research. Each issue contains informative articles covering

Alizyme Therapeutics Limited

Alizyme is a drug development company. It develops new products to treat diseases with high unmet medical need and substantial market opportunity. To date it has focussed on obesity and related diseases, such as diabetes, and on gastrointestinal disorders including irritable bowel syndrome, inflammatory bowel disease and mucositis, a serious side effect of cancer therapy.Alizyme takes drug product...

Clinical Data, Inc

Founded in 1972, Clinical Data, Inc. is a worldwide leader in providing comprehensive molecular and pharmacogenomics services as well as clinical diagnostics to improve patient care. The Company is organized under three worldwide divisions segmented by service offerings and varying client constituents: PGxHealth™, Cogenics™, Vital Diagnostics™.Clinical Data’s genetic test division, PGxHeal...

eClinical Solutions

eClinical Solutions, a division of Eliassen Group, takes a strategic approach to managing clinical trial data by combining data management with statistical programming, reporting and customized training solutions integrated with a clinical data repository to deliver a complete end-to-end data management solution. With experience across a wide range of ther...

Tempus

Tempus is a technology company that is building the world’s largest library of molecular and clinical data and an operating system to make that data accessible and useful. We enable physicians to deliver personalized cancer care for patients through our interactive analytical and machine learning platform. We provide genomic sequencing services and an...

Oncolytics Biotech Inc.

Oncolytics Biotech Inc. was formed in 1998 to develop its proprietary product, REOLYSIN®, as a potential therapeutic for a wide variety of human cancers. Oncolytics has completed five clinical trials with REOLYSIN® in Canada and the U.K. and is currently conducting four Phase I or Phase I/II REOLYSIN® trials in the U.K. and the U.S. The company also has permission to commence a Phase II combina...

NexGenix Pharmaceuticals Holdings, Inc.

NexGenix Pharmaceuticals was formed to pursue recent major advances in genetic and signal transduction research for the benefit of patients with neurofibromatosis. By concentrating much of the world's basic science and clinical expertise on NF in one company we are accelerating treatments to patients. NexGenix is the first and only company to focus on NF.

The Medical Genome Initiative

The Medical Genome Initiative is a consortium of leading clinical laboratories and research organizations in the U.S. and Canada with a mission to expand access to high-quality clinical whole genome sequencing (cWGS) for the diagnosis of genetic disease. The initial focus of the Medical Genome Initiative will be to publish recommended laboratory and clinic...

Abt Associates

Abt Bio-Pharma Solutions, Inc. (ABS) provides integrated clinical, health economic, and commercialization services to the pharmaceutical, biotechnology, medical device, and diagnostics industries worldwide. The company specializes in demonstrating the value, safety, and efficacy of health technologies through prospective studies as well as through retrospective data analyses, models, and quantitat...

AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals is a privately held pharmaceutical company dedicated to the development and commercialization of new therapies for the treatment of pain and other conditions where there is an unmet need for improved safety and efficacy. The company applies its proprietary dosage form and delivery technologies to enhance the safety, therapeutic benefit and commercial attractiveness of curren...

Shared Health

With Clinical Insight, clinicians can access a practice management tool that presents a broad view of the care delivered across their patient population. Clinical Insight allows practices to generate reports that determine opportunities to provide care for specific groups of patients and ultimately improve outcomes for all patients.

Formula Pharmaceuticals, Inc. and Rockland Immunochemicals, Inc.

Formula Pharmaceuticals is a privately held, immuno-oncology focused company located in Berwyn, Pennsylvania focused on the development of CAR immunotherapy for oncology and autoimmune diseases. Formula’s technology platform offers important opportunities for improvements to existing CAR approaches, with the objective to significantly increase patient...

DSG, Inc.

DSG, Inc. supports clinical trial data collection and management with innovative technology solutions, including Electronic Data Capture with specialized Clinical Data Management services, IWRS, Clinical Trial Management Systems and digital on-demand Case Report Form publishing management software. DSG’s products allow user-friendly, accurate and effi...

Pilot Pharmaceuticals

Pilot Pharmaceuticals develops novel products to treat CNS disorders with unmet medical need and substantial market size. The Company takes candidate drugs from an early discovery stage into clinical development.Pilot Pharmaceuticals will license its products to pharmaceutical companies, allowing them to complete the clinical development, gain regulatory approval and market the product.Pilot Pharm...


More From BioPortfolio on "Pieris Pharmaceuticals Presents Data Demonstrating Monotherapy Clinical Benefit"

Quick Search

Corporate Database Quicklinks